Literature DB >> 1750501

AIDS-associated Kaposi's sarcoma-derived cells in long-term culture express and synthesize smooth muscle alpha-actin.

H A Weich1, S Z Salahuddin, P Gill, S Nakamura, R C Gallo, J Folkmann.   

Abstract

Spindle-shaped cells from Kaposi's sarcoma lesions (AIDS-KS cells) were cultured for long periods in the presence of conditioned medium from activated CD4-positive T cells (HTLV-II infected transformed nonvirus producer) and characterized under in vitro conditions. To investigate a possible vascular origin, AIDS-KS cells were analyzed for the presence of smooth muscle alpha-actin, a differentiation marker for vascular smooth muscle cells. Immunofluorescence studies using a monoclonal antibody for smooth muscle alpha-actin demonstrated positive staining of the AIDS-KS cells (KS-3 and KS-4) but not by endothelial cells or fibroblasts. Northern blot analysis using an oligonucleotide probe unique for human smooth muscle alpha-actin indicated the expression of this gene by AIDS-KS cells. Similar analysis of biopsies from the KS lesion showed that in addition to the staining of smooth muscle cells associated with the blood vessels, the tumor-related spindle cells also stained positively. These cells were also analyzed for the expression of different growth factor genes. The platelet-derived growth factor (PDGF) A-chain gene was expressed at a moderate level. The insulin-like growth factor-1 (IGF-1) and insulin-like growth factor-2 (IGF-2) genes were not overexpressed in relation to control cells. These data suggest that the analyzed AIDS-KS cells may be smooth muscle-like cells and therefore of vascular origin. Based on these results as well as previous reports, we speculate that cells of the immune system may regulate growth of cells in the vascular wall by a novel pathway.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1750501      PMCID: PMC1886449     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  The long 3'-untranslated regions of the PDGF-A and -B mRNAs are only distantly related.

Authors:  J Hoppe; L Schumacher; W Eichner; H A Weich
Journal:  FEBS Lett       Date:  1987-11-02       Impact factor: 4.124

2.  Expression of the sis gene by endothelial cells in culture and in vivo.

Authors:  T B Barrett; C M Gajdusek; S M Schwartz; J K McDougall; E P Benditt
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

3.  Platelet-derived growth factor. Phorbol ester induces the expression of the B-chain but not of the A-chain in HEL cells.

Authors:  H A Weich; D Herbst; H U Schairer; J Hoppe
Journal:  FEBS Lett       Date:  1987-03-09       Impact factor: 4.124

4.  Tissue-specific expression of insulin-like growth factor II mRNAs with distinct 5' untranslated regions.

Authors:  J C Irminger; K M Rosen; R E Humbel; L Villa-Komaroff
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

5.  Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells.

Authors:  M W Majesky; E P Benditt; S M Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

6.  Rat skeletal myoblasts and arterial smooth muscle cells express the gene for the A chain but not the gene for the B chain (c-sis) of platelet-derived growth factor (PDGF) and produce a PDGF-like protein.

Authors:  T Sejersen; C Betsholtz; M Sjölund; C H Heldin; B Westermark; J Thyberg
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury.

Authors:  L Jonasson; J Holm; G K Hansson
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

8.  The human osteosarcoma cell line U-2 OS expresses a 3.8 kilobase mRNA which codes for the sequence of the PDGF-B chain.

Authors:  H A Weich; W Sebald; H U Schairer; J Hoppe
Journal:  FEBS Lett       Date:  1986-03-31       Impact factor: 4.124

9.  Transforming gene from human stomach cancers and a noncancerous portion of stomach mucosa.

Authors:  H Sakamoto; M Mori; M Taira; T Yoshida; S Matsukawa; K Shimizu; M Sekiguchi; M Terada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

10.  A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation.

Authors:  O Skalli; P Ropraz; A Trzeciak; G Benzonana; D Gillessen; G Gabbiani
Journal:  J Cell Biol       Date:  1986-12       Impact factor: 10.539

View more
  18 in total

1.  Contradictory Concepts in the Etiology and Regression of Kaposi's Sarcoma. The Ferenc Györkey Memorial Lecture.

Authors:  Joseph G Sinkovics
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma.

Authors:  Qi Ma; Lucas E Cavallin; Bin Yan; Shoukang Zhu; Elda Margarita Duran; Huili Wang; Laura P Hale; Chunming Dong; Ethel Cesarman; Enrique A Mesri; Pascal J Goldschmidt-Clermont
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-08       Impact factor: 11.205

3.  Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth.

Authors:  M C Amaral; S Miles; G Kumar; A E Nel
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

4.  Oncostatin-M is an autocrine growth factor in Kaposi's sarcoma.

Authors:  J Cai; P S Gill; R Masood; P Chandrasoma; B Jung; R E Law; S F Radka
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

5.  KSHV-induced notch components render endothelial and mural cell characteristics and cell survival.

Authors:  Ren Liu; Xiuqing Li; Anil Tulpule; Yue Zhou; Jeffrey S Scehnet; Shaobing Zhang; Jong-Soo Lee; Preet M Chaudhary; Jae Jung; Parkash S Gill
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

6.  Human immunodeficiency virus-associated oral Kaposi's sarcoma. A heterogeneous cell population dominated by spindle-shaped endothelial cells.

Authors:  J A Regezi; L A MacPhail; T E Daniels; Y G DeSouza; J S Greenspan; D Greenspan
Journal:  Am J Pathol       Date:  1993-07       Impact factor: 4.307

7.  Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor.

Authors:  Y M Zhang; S Bachmann; C Hemmer; J van Lunzen; A von Stemm; P Kern; M Dietrich; R Ziegler; R Waldherr; P P Nawroth
Journal:  Am J Pathol       Date:  1994-01       Impact factor: 4.307

Review 8.  Malignant tumours in patients with HIV infection.

Authors:  U Tirelli; S Franceschi; A Carbone
Journal:  BMJ       Date:  1994-04-30

9.  The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence.

Authors:  G Barillari; R Gendelman; R C Gallo; B Ensoli
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

10.  Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma.

Authors:  N Dupin; C Fisher; P Kellam; S Ariad; M Tulliez; N Franck; E van Marck; D Salmon; I Gorin; J P Escande; R A Weiss; K Alitalo; C Boshoff
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.